- Feature Paper
- Article
The Design and Cell-Free Protein Synthesis of a Pembrolizumab Single-Chain Variable Fragment
- Landon E. Ebbert,
- Tyler J. Free,
- Mehran Soltani and
- Bradley C. Bundy
Background/Objectives: Cancer is a leading cause of death. However, recently developed immunotherapies have shown significant promise to improve cancer treatment outcomes and survival rates. Pembrolizumab, a cancer immunotherapy drug, enables a stron...